<DOC>
	<DOCNO>NCT02357381</DOCNO>
	<brief_summary>A multi-center , prospective , non-randomized , single arm , open label , post-market , observational study evaluate use eneura , springtms system reduction migraine headache symptom .</brief_summary>
	<brief_title>eNeura SpringTMS Post-Market Observational US Study Migraine</brief_title>
	<detailed_description>A prospective , non-randomized , single arm , multi-center observational study design evaluate use SpringTMS system reduce frequency headache day . Note : This NON-SIGNIFICANT RISK ( NSR ) study NON-SIGNIFICANT RISK ( NSR ) Device . It post market study NSR device clear FDA 510 ( k ) pre-market notification process . The cleared indication use provide . This NSR study design collect information additional application SpringTMS device . These additional application include : 1 . Use device evaluate potential regular use sTMS reduce frequency , severity , and/or duration migraine . 2 . Delivery additional treatment ( pulse ) evaluate acute treatment efficacy breakthrough migraine attack without aura .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<criteria>1 . Patients 18 65 year age ; 2 . Patients able understand communicate English ; 3 . Migraine without aura ; 4 . 425 headache day per month ( confirm 1month baseline diary , minimum 5 complete headachefree days/month ) ; 5 . Understand willing provide diary survey data . Subjects exclude participate trial meet follow criterion 1 . Severe coexist disease life expectancy le 1 year ; 2 . Currently involve investigational clinical trial complete primary endpoint may interfere SpringTMS study result ; 3 . Mental impairment condition may allow subject understand nature , significance scope study cooperate followup requirement ; 4 . Known drug and/or alcohol addiction use illicit substance ; 5 . Patients epilepsy history seizure ; 6 . Severe active major depression major psychiatric illness ; 7 . Concurrent use neurostimulation device ( Cefaly® , TENS , implantable device ) ; 8 . Use Botox® within past 4 month ; 9 . Extracranial nerve block ( e.g . occipital , supraorbital ) within past 3 month ; 10 . Use Cefaly prevention within past month ; 11 . Patients metal contain implant follow : The SpringTMS may use patient metal , conductive material , metalcontaining implant head , neck upper body . Patients implant affect magnetic field use SpringTMS . Examples implant include : Aneurysm clip coil • Radioactive seed Cochlear implant • Magnetically programmable shunt valve Cerebral spinal fluid shunt • Stents Bullets pellets lodge head upper body • Metal plate , screw , staple suture skull , neck , shoulder , arm hand Filters • Metallic artificial heart valve Electrodes • Facial tattoo metallic ink Dental implant , filling , dental appliance okay affect device . Note : although explicitly exclude , safety effectiveness establish pregnant woman . Please defer judgment investigator consider eligibility population .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>